Macquarie-led consortium offers 870p per share for Renewi, with strong shareholder support and positive investment outlook. Regulatory approvals pending.
What is covered in the Full Insight:
Introduction
Macquarie's Bid for Renewi
Background and Rationale
Irrevocable Undertakings and Shareholder Support
Conditions and Approvals
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.